Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy

Browse by...

Deposit

Highlights

More informations

Title		Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy
Authors		Girardin, François Painter, Chris Hearmon, Natalie Eddowes, Lucy Kaiser, Stefan Negro, Francesco Vernaz-Hegi, Nathalie
Published in		JHEP Reports : Innovation in Hepatology. 2021, p. 100279
Identifiers		DOI: 10.1016/j.jhepr.2021.100279
Full text		Article (Accepted version) (1.9 MB) - Free access Other version: https://linkinghub.elsevier.com/retrieve/pii/S2589555921000550
Structures		Faculté de médecine / Section de médecine clinique / Département de psychiatrie Faculté de médecine / Section de médecine clinique / Département de médecine Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
Research groups		Psychopathologie clinique et expérimentale (987) Etudes et traitement de l'hépatite C et B (554)
Citation (ISO format)		GIRARDIN, François et al. Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy. In: JHEP Reports : Innovation in Hepatology, 2021, p. 100279. doi: 10.1016/j.jhepr.2021.100279 https://archive-ouverte.unige.ch/unige:151338

49 hits

7 downloads

Deposited on : 2021-04-29

Export document

Archive ouverte UNIGE